STOCK TITAN

electroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

electroCore, Inc. (Nasdaq: ECOR) will announce its first quarter financial results on May 8, 2024, after the market closes. The company, specializing in bioelectronic medicine and wellness, will hold a conference call to discuss the results and answer questions.

electroCore, Inc. (Nasdaq: ECOR) annuncerà i risultati finanziari del primo trimestre l'8 maggio 2024, dopo la chiusura del mercato. La società, specializzata in medicina bioelettronica e benessere, terrà una conferenza telefonica per discutere i risultati e rispondere alle domande.
electroCore, Inc. (Nasdaq: ECOR) anunciará sus resultados financieros del primer trimestre el 8 de mayo de 2024, después del cierre del mercado. La empresa, especializada en medicina bioelectrónica y bienestar, realizará una conferencia telefónica para discutir los resultados y responder preguntas.
electroCore, Inc.(Nasdaq: ECOR)는 2024년 5월 8일 시장 마감 후 1분기 재무 결과를 발표할 예정입니다. 생체전자 의학 및 웰니스를 전문으로 하는 이 회사는 결과에 대해 논의하고 질문에 답하기 위해 컨퍼런스 콜을 개최할 것입니다.
electroCore, Inc. (Nasdaq: ECOR) annoncera ses résultats financiers pour le premier trimestre le 8 mai 2024, après la fermeture du marché. L'entreprise, spécialisée en médecine bioélectronique et bien-être, tiendra une conférence téléphonique pour discuter des résultats et répondre aux questions.
electroCore, Inc. (Nasdaq: ECOR) wird seine Finanzergebnisse für das erste Quartal am 8. Mai 2024 nach Börsenschluss bekannt geben. Das Unternehmen, das auf bioelektronische Medizin und Wellness spezialisiert ist, wird eine Telefonkonferenz abhalten, um die Ergebnisse zu diskutieren und Fragen zu beantworten.
Positive
  • None.
Negative
  • None.

ROCKAWAY, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial results for the first quarter ended March 31, 2024, after the close of the market on Wednesday, May 8, 2024. Management will host a conference call and webcast at 4:30 PM EDT to discuss the financial results and answer questions.

Wednesday, May 8, 4:30 PM EDT
Domestic: 877-407-8835
International: located here
Conference ID: 13744118
Webcast:  electroCore Earnings Webcast

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.

For more information, visit www.electrocore.com.

Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com


FAQ

When will electroCore announce its first quarter financial results for March 31, 2024?

electroCore will announce its first quarter financial results on Wednesday, May 8, 2024, after the market closes.

What is the stock symbol of electroCore?

electroCore's stock symbol is ECOR.

How can I participate in the conference call to discuss the financial results?

You can participate in the conference call by dialing 877-407-8835 (Domestic) or the international number provided, using the Conference ID: 13744118. Additionally, you can join the webcast on electroCore's Earnings Webcast.

electroCore, Inc.

NASDAQ:ECOR

ECOR Rankings

ECOR Latest News

ECOR Stock Data

66.86M
4.91M
25.02%
16.11%
0.67%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
ROCKAWAY